(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QUANTUM NEUROLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

QUANTUM NEUROLOGY

ST13

US500000077186161

Class

9

Filing

77186161

Registration

3609330

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

06/19/2020

Trademark type

Word

Nice classes

9

Filing date

05/21/2007

Registration date

04/21/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/19/2020

Last transaction

06/19/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/19/2008

First use in commerce

06/19/2008

Drawing code

4

Owner type

03

Owner location

Los Angeles, CA, US

Examiner

KHAN, ASMAT

Law office

M50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

GRT Solutions, Inc.

Representatives

John D. Titus HARTMAN TITUS PLC

Technical classification

Nice Classes

Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Digital mediaCDsDVDsdownloadable audio and audio visual files featuring instructions in the field of neurology

Publications

History of USPTO decisions and trademark events.

39 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/19/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/19/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/19/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

04/14/2020

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

10/31/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/29/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

10/09/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/07/2018

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/21/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

05/01/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/01/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/01/2015

E815

TEAS SECTION 8 & 15 RECEIVED

04/20/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/21/2011

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/12/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

04/21/2009

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

03/13/2009

ALIE

ASSIGNED TO LIE

03/13/2009

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/12/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/03/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/03/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/03/2009

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/31/2008

GNRT

NON-FINAL ACTION E-MAILED

12/31/2008

CNRT

SU - NON-FINAL ACTION - WRITTEN

12/31/2008

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/04/2008

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/04/2008

IUAF

USE AMENDMENT FILED

07/22/2008

EISU

TEAS STATEMENT OF USE RECEIVED

07/22/2008

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/01/2008

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

05/20/2008

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

12/04/2007

PUBO

PUBLISHED FOR OPPOSITION

11/06/2007

NPUB

NOTICE OF PUBLICATION

10/17/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/03/2007

ALIE

ASSIGNED TO LIE

10/03/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/04/2007

DOCK

ASSIGNED TO EXAMINER

08/31/2007

NWAP

NEW APPLICATION ENTERED

05/24/2007

Continuous trademark protection

Get notified about every new filing that threatens QUANTUM NEUROLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.